Stay updated on Nivolumab Combo in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:14:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:02.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, with a minimal header and a Home link, replacing the usual study details and navigation.
    Difference
    19%
    Check dated 2026-09-22T23:26:51.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays revision: v3.7.0 instead of v3.6.6, indicating a new release. This metadata change does not affect the study details or how the page works.
    Difference
    0.0%
    Check dated 2026-09-15T22:18:28.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous v3.6.5, indicating a new page revision has been published. The update appears to be a backend/metadata change rather than a user-facing content modification.
    Difference
    0.0%
    Check dated 2026-09-01T19:32:03.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study record now includes a funding line indicating the U.S. NIH grant/contract under the Study ID Numbers. This clarifies the financial support for the U.S. portion of the trial without altering its design or results.
    Difference
    0.0%
    Check dated 2026-08-25T20:32:43.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head and Neck Cancer Clinical Trial page.